Squarepoint’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-117,679
| Closed | -$671K | – | 2839 |
|
|
2025
Q1 | $671K | Buy |
117,679
+75,189
| +177% | +$429K | ﹤0.01% | 1731 |
|
|
2024
Q4 | $417K | Sell |
42,490
-60,696
| -59% | -$596K | ﹤0.01% | 2035 |
|
|
2024
Q3 | $841K | Buy |
103,186
+94,446
| +1,081% | +$770K | ﹤0.01% | 1513 |
|
|
2024
Q2 | $117K | Sell |
8,740
-9,857
| -53% | -$132K | ﹤0.01% | 2237 |
|
|
2024
Q1 | $863K | Buy |
18,597
+18,217
| +4,794% | +$845K | ﹤0.01% | 1421 |
|
|
2023
Q4 | $25.7K | Buy |
+380
| New | +$25.7K | ﹤0.01% | 2416 |
|
|
2023
Q2 | – | Sell |
-36,377
| Closed | -$1.94M | – | 2483 |
|
|
2023
Q1 | $1.94M | Buy |
+36,377
| New | +$1.94M | 0.01% | 847 |
|
|
2022
Q3 | – | Sell |
-2,297
| Closed | -$219K | – | 2174 |
|
|
2022
Q2 | $219K | Buy |
2,297
+696
| +43% | +$66.4K | ﹤0.01% | 1699 |
|
|
2022
Q1 | $258K | Buy |
+1,601
| New | +$258K | ﹤0.01% | 1804 |
|